Medical Representative (Bucuresti) |
 |
| Compania: Ipsen Pharma |
|
|
|
| Expirat la: 09.03.2012 |
| Actualizat la: 08.03.2012 |
|
|
| Compania: |
Ipsen Pharma |
| Departament: |
Chimie, Biochimie, Farmacie, Healthcare, Marketing, CercetariMarketing, Sondaje, MedicinaUmana, Veterinara, Stomatologie, Sales, Vanzari, Comert |
| Orasul: |
Bucuresti
|
| Tip Job: |
Full time |
| Posturi disponibile: |
1 |
|
| Nivel cariera: |
Entry-Level/Primii 3 Ani Exp,Mid-Level/Peste 3 Ani Exp |
| Limbi Straine: |
engleza, |
| Oferta: |
nespecificat |
| Permis conducere: |
B |
| Data introducerii: |
06.02.2012 |
| Data limita: |
08.03.2012 |
|
|
| CANDIDATUL IDEAL:
Education:
- Ideal: Graduate diploma in Medicine or Pharmacy
- Minimum: Graduate diploma in collateral specialities : Biology, Chemistry
- Languages: Business knowledge - English (written and spoken)
Experience:
- Experience in similar position, preferably in a multinational company (2 or more years )
Communication (Level / Nature):
- Internal contacts: Communication& people management skills, team-player, presentation skills | RESPONSABILITATI / BENEFICII:
Main Duties to be performed:
- develop and maintain business relationships with customers and provide them with information about company products;
- responsible for promotion of company products and management of assigned territory to achieve budget
- develop and maintain territory coverage, using journey plans to assure maximum coverage of territory
- provide relevant intelligence about marketplace and competition
- organise local seminars and symposia, round tables and group meetings (presenting therapy, trends of treatment, products)
Specifics of Position:
- could be involved in training of junior staff
- may also be assigned special projects or tasks on an as-needed basis | DESCRIEREA COMPANIEI:
Ipsen is a global biotechnology specialty care Group with total sales in excess of 1.1 billion euros in 2011, and total worldwide staff of more than 4,400.
Its strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology, and primary care drugs, significantly contributing to research financing. This strategy is also supported by an active policy of partnerships. Ipsen’s specific Research & Development (R&D) centers and peptide & protein engineering platform give the Group a competitive edge. More than 800 people are dedicated to the discovery and development of innovative drugs for patient care. In 2010, R&D spend reached close to €200 million, representing more than 19% of total Group sales.
|
|
|
|
|